Eurofins-Cerep SA Cash Flow Conversion Efficiency

Latest as of June 2025: -0.043x

Eurofins-Cerep SA cash flow conversion efficiency. Based on the latest financial reports, Eurofins-Cerep SA (ALECR) has a cash flow conversion efficiency ratio of -0.043x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.19 Million ≈ $-3.73 Million USD) by net assets (€73.54 Million ≈ $85.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Eurofins-Cerep SA (2001–2017)

Cash flow conversion efficiency of Eurofins-Cerep SA from 2001 to 2017. This chart illustrates how Eurofins-Cerep SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Eurofins-Cerep SA (ALECR) share price today for real-time trading data and today's change.

Eurofins-Cerep SA Cash Flow Conversion Ratio Explained

Eurofins-Cerep SA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Eurofins-Cerep SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eurofins-Cerep SA ranked by their cash flow conversion efficiency. Also see Eurofins-Cerep SA (ALECR) market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Novus Holdings Ltd
JSE:NVS
0.209x
Ying Han Technology Co Ltd
TW:4562
0.009x
Nabaltec AG
F:NTG
-0.054x
Kingfisher Metals Corp
V:KFR
-0.005x
Conrad Asia Energy Ltd
AU:CRD
-0.295x
OPPSTAR
KLSE:0275
0.029x
Tsang Yow Industrial Co Ltd
TW:1568
0.033x
Ufuk Yatirim Yonetim Ve Gayrimenkul AS
IS:UFUK
0.000x

Annual Cash Flow Conversion Efficiency for Eurofins-Cerep SA (2001–2017)

The table below shows the annual cash flow conversion efficiency of Eurofins-Cerep SA from 2001 to 2017. Review ALECR free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2017-12-31 €21.31 Million
≈ $24.91 Million
€4.24 Million
≈ $4.95 Million
0.199x -37.92%
2016-12-31 €17.46 Million
≈ $20.41 Million
€5.59 Million
≈ $6.54 Million
0.320x +1002.79%
2015-12-31 €14.97 Million
≈ $17.50 Million
€434.88K
≈ $508.42K
0.029x +116.50%
2014-12-31 €13.16 Million
≈ $15.39 Million
€-2.32 Million
≈ $-2.71 Million
-0.176x -328.97%
2013-12-31 €13.35 Million
≈ $15.60 Million
€1.03 Million
≈ $1.20 Million
0.077x -5.29%
2012-12-31 €13.93 Million
≈ $16.29 Million
€1.13 Million
≈ $1.32 Million
0.081x -68.70%
2011-12-31 €13.57 Million
≈ $15.86 Million
€3.52 Million
≈ $4.11 Million
0.259x +421.40%
2010-12-31 €13.63 Million
≈ $15.94 Million
€-1.10 Million
≈ $-1.29 Million
-0.081x -228.71%
2009-12-31 €18.90 Million
≈ $22.10 Million
€1.19 Million
≈ $1.39 Million
0.063x -72.44%
2008-12-31 €21.47 Million
≈ $25.10 Million
€4.88 Million
≈ $5.71 Million
0.227x +29.62%
2007-12-31 €23.92 Million
≈ $27.96 Million
€4.20 Million
≈ $4.91 Million
0.175x +199.55%
2006-12-31 €14.12 Million
≈ $16.51 Million
€-2.49 Million
≈ $-2.91 Million
-0.176x -391.06%
2005-12-31 €31.13 Million
≈ $36.40 Million
€1.89 Million
≈ $2.20 Million
0.061x -79.31%
2004-12-31 €32.05 Million
≈ $37.47 Million
€9.38 Million
≈ $10.97 Million
0.293x +139.87%
2003-12-31 €29.66 Million
≈ $34.68 Million
€3.62 Million
≈ $4.23 Million
0.122x -16.88%
2002-12-31 €29.32 Million
≈ $34.28 Million
€4.30 Million
≈ $5.03 Million
0.147x +159.56%
2001-12-31 €26.17 Million
≈ $30.60 Million
€1.48 Million
≈ $1.73 Million
0.057x --

About Eurofins-Cerep SA

PA:ALECR France Diagnostics & Research
Market Cap
$108.50 Million
€92.81 Million EUR
Market Cap Rank
#19342 Global
#288 in France
Share Price
€18400.00
Change (1 day)
+0.00%
52-Week Range
€15000.00 - €18600.00
All Time High
€18600.00
About

Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was foun… Read more